BioScience Health Innovations (BHIC) Accumulated Expenses (2020 - 2025)
Historic Accumulated Expenses for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to $6686.0.
- BioScience Health Innovations' Accumulated Expenses rose 16744.0% to $6686.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6686.0, marking a year-over-year increase of 16744.0%. This contributed to the annual value of $5993.0 for FY2024, which is 31331.03% up from last year.
- Latest data reveals that BioScience Health Innovations reported Accumulated Expenses of $6686.0 as of Q3 2025, which was up 16744.0% from $24500.0 recorded in Q2 2025.
- In the past 5 years, BioScience Health Innovations' Accumulated Expenses registered a high of $24500.0 during Q2 2025, and its lowest value of $450.0 during Q3 2021.
- Over the past 5 years, BioScience Health Innovations' median Accumulated Expenses value was $1947.5 (recorded in 2024), while the average stood at $5631.2.
- Its Accumulated Expenses has fluctuated over the past 5 years, first plummeted by 9100.0% in 2021, then surged by 112500.0% in 2025.
- Quarter analysis of 5 years shows BioScience Health Innovations' Accumulated Expenses stood at $450.0 in 2021, then changed by 0.0% to $450.0 in 2022, then surged by 222.22% to $1450.0 in 2023, then soared by 313.31% to $5993.0 in 2024, then rose by 11.56% to $6686.0 in 2025.
- Its Accumulated Expenses was $6686.0 in Q3 2025, compared to $24500.0 in Q2 2025 and $20750.0 in Q1 2025.